Group One Trading’s Allogene Therapeutics ALLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $9.79K | Buy |
4,014
+1,246
| +45% | +$2.5K | ﹤0.01% | 6389 |
|
|
2025
Q4 | $3.79K | Buy |
2,768
+500
| +22% | +$660 | ﹤0.01% | 7300 |
|
|
2025
Q3 | $2.81K | Buy |
+2,268
| New | +$2.7K | ﹤0.01% | 7791 |
|
|
2025
Q1 | – | Sell |
-5,362
| Closed | -$10.1K | – | 7519 |
|
|
2024
Q4 | $11.4K | Sell |
5,362
-10,800
| -67% | -$26.6K | ﹤0.01% | 6033 |
|
|
2024
Q3 | $45.3K | Buy |
16,162
+15,718
| +3,540% | +$41.9K | ﹤0.01% | 4725 |
|
|
2024
Q2 | $1.03K | Sell |
444
-58,480
| -99% | -$173K | ﹤0.01% | 6354 |
|
|
2024
Q1 | $263K | Buy |
58,924
+21,365
| +57% | +$89.1K | ﹤0.01% | 3323 |
|
|
2023
Q4 | $121K | Sell |
37,559
-17,600
| -32% | -$49.9K | ﹤0.01% | 4300 |
|
|
2023
Q3 | $175K | Buy |
55,159
+48,153
| +687% | +$211K | ﹤0.01% | 3916 |
|
|
2023
Q2 | $34.8K | Sell |
7,006
-3,606
| -34% | -$19.5K | ﹤0.01% | 5561 |
|
|
2023
Q1 | $52.4K | Buy |
10,612
+10,324
| +3,585% | +$66.2K | ﹤0.01% | 4809 |
|
|
2022
Q4 | $1.81K | Buy |
+288
| New | +$2.67K | ﹤0.01% | 6684 |
|
|
2022
Q1 | – | Sell |
-12,460
| Closed | -$130K | – | 7964 |
|
|
2021
Q4 | $186K | Buy |
12,460
+9,344
| +300% | +$165K | ﹤0.01% | 5157 |
|
|
2021
Q3 | $80K | Sell |
3,116
-1,434
| -32% | -$34K | ﹤0.01% | 6122 |
|
|
2021
Q2 | $119K | Sell |
4,550
-15,193
| -77% | -$433K | ﹤0.01% | 5786 |
|
|
2021
Q1 | $697K | Buy |
19,743
+18,830
| +2,062% | +$635K | ﹤0.01% | 3649 |
|
|
2020
Q4 | $23K | Buy |
+913
| New | +$29.8K | ﹤0.01% | 5433 |
|
|
2020
Q1 | – | Sell |
-6,005
| Closed | -$156K | – | 5187 |
|
|
2019
Q4 | $156K | Buy |
6,005
+5,300
| +752% | +$146K | ﹤0.01% | 3337 |
|
|
2019
Q3 | $19K | Sell |
705
-35
| -5% | -$997 | ﹤0.01% | 4355 |
|
|
2019
Q2 | $20K | Buy |
740
+500
| +208% | +$13.9K | ﹤0.01% | 4170 |
|
|
2019
Q1 | $7K | Buy |
+240
| New | +$6.96K | ﹤0.01% | 4357 |
|
Other funds holding ALLO
P
TGA
VCM
